Table 3.
Clinical Data | No Hemorrhagic Transformation | Hemorrhagic Transformation | p-value | ||
---|---|---|---|---|---|
No. / Mean | (%) / SD | No. / Mean | (%) / SD | ||
Systolic Blood Pressure | 146.64 | 31.285 | 138.85 | 27.628 | 0.207 |
Diastolic Blood Pressure | 85.41 | 16.054 | 84.04 | 12.802 | 0.663 |
WBC | 9.68 | 3.79 | 14.50 | 14.02 | 0.001 |
Hematocrit | 40.00 | 5.89 | 39.71 | 7.14 | 0.808 |
Platelet Count | 250.11 | 90.04 | 232.54 | 105.50 | 0.321 |
EGFR | 67.18 | 25.42 | 68.21 | 17.12 | 0.831 |
Total Cholesterol | 183.41 | 52.18 | 169.91 | 49.35 | 0.228 |
LDL Cholesterol | 114.98 | 45.99 | 105.09 | 49.51 | 0.330 |
Atrial Fibrillation | 43 | 79.6% | 11 | 20.4% | 0.001 |
Sulfonylurea Use | 85 | 95.5% | 4 | 4.5% | 0.617 |
Prior Statin Use | 140 | 94.6% | 8 | 5.4% | 0.891 |
Pre-admission Antithrombotic | 145 | 92.9% | 11 | 7.1% | 0.346 |
Myocardial Infarction | 9 | 75.0% | 3 | 25.0% | 0.003 |
HbA1c | 6.71 | 1.812 | 6.22 | 1.476 | 0.202 |
HbA1c | 0.217 | ||||
Normal | 175 | 92.1% | 15 | 7.9% | |
Low | 8 | 88.9% | 1 | 11.1% | |
High | 203 | 96.7% | 7 | 3.3% |